http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0609292-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b21f650fc35b3e1947103e89adb06f3f |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
filingDate | 1992-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca11b49ffa8530361ab93decdd7e4945 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1191ee418cc76ba322e612295dae725f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3521891ebaf96ce25f7f583a55fb69f8 |
publicationDate | 1994-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0609292-A1 |
titleOfInvention | Soluble variants of type i membrane proteins, and methods of using them |
abstract | The invention relates to novel soluble variants of the type I membrane protein, called protein GA733-2, as well as to methods of producing and using the same. The invention further describes a method for converting type I membrane proteins into secretory proteins which can be used for active immunotherapy against carcinomas and as reagents in detecting expression of GA733-2 proteins in cells tumor. |
priorityDate | 1991-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 703.